
























![]()
Orion Oyj (ORINF) Q1 2026 Earnings Call April 23, 2026 7:00 AM EDT
Company Participants
Tuukka Hirvonen - Investor Relations & Financial Communications Officer
Liisa Hurme - President, CEO & Chairman of Executive Management Board
Rene Lindell - CFO & Member of Group Executive Management Board
Conference Call Participants
Alexander Moore - BofA Securities, Research Division
Sami Sarkamies - Danske Bank A/S, Research Division
Anssi Raussi - SEB, Research Division
Iiris Theman - DNB Carnegie, Research Division
Presentation
Tuukka Hirvonen
Investor Relations & Financial Communications Officer
Good afternoon, and welcome to Orion's Q1 2026 Results Webcast and Conference Call. My name is Tuukka Hirvonen, and I'm the Head of IR here at Orion. In a few moments, we will kick off with the presentation by our CEO, Liisa Hurme, after which you will have the possibility to ask questions either from Liisa or from our CFO, René Lindell.
We will be first taking the questions through the conference call lines. And after that, we will turn on to the webcast chat function. So you may also type in your questions using the chat function of this webcast. And to our Finnish-speaking viewers, this event is held in English. But afterwards, later this afternoon, you will find a Finnish interview of Orion's CEO, Liisa Hurme on Orion's website.
And just before letting Liisa to step in, just a reminder about this disclaimer regarding forward-looking statements.
With these words, I'd like to hand over to Liisa.
Liisa Hurme
President, CEO & Chairman of Executive Management Board
Thank you, Tuukka, and good afternoon on my behalf as well, and welcome to listen Orion Q1 2026 results. Some highlights from this Q1. All our businesses performed solid in a solid way and very well, I would say so. And we also have good news regarding our clinical pipeline. We've been granted -- ODM-212 has been granted orphan drug
此内容由惯性聚合(RSS阅读器)自动聚合整理,仅供阅读参考。 原文来自 — 版权归原作者所有。